Abstract
Maternal exposure to angiotensin-converting enzyme (ACE) inhibitors has consistently been associated with significant fetal toxicity. We report the case of a 24-year-old woman, gravida 3, para 1-0-1-1 who presented at 24 2/7 weeks' gestation with initial abnormal fetal sonographic findings, including severe oligohydramnios, misshapen cranium, pericardial effusion, small bladder, and echogenic bowel, all after prolonged exposure to multiple medications including an ACE inhibitor. Eighteen days after discontinuation of the ACE inhibitor, repeat fetal sonography revealed normal amniotic fluid and normal cranial and fetal anatomy. The patient gave birth to a normal infant at 36 weeks' gestation. Poor neonatal outcome with prolonged antenatal exposure to ACE inhibitors is not inevitable. Early follow up sonographic evaluation in patients with prolonged exposure to ACE inhibitors may allow physicians to more accurately counsel patients on pregnancy outcome.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Braunwald E . Heart Disease: A Textbook of Cardiovascular Medicine St Louis, MO: WB Saunders 2001
Barr M . Teratogen update: angiotensin-converting enzyme inhibitors Teratology 1994 50: 399–409
Henshaw SK . Unintended pregnancy in the United States Fam Plan Perspect 1998 30: 24–9, 46
Pryde PG, Sedman AB, Nugent CE, Barr M Jr . Angiotensin-converting enzyme inhibitor fetopathy J Am Soc of Nephrol 1993 3: 1575–82
Pryde PG, Barr M Jr . Low-dose, short-acting, angiotensin-converting enzyme inhibitors as rescue therapy in pregnancy Obstet Gynecol 2001 97: 799–800
Lip GY, Churchill D, Beevers M, Auckett A, Beevers DG . Angiotensin-converting-enzyme inhibitors in early pregnancy Lancet 1997 350: 1446–7
Burrows RF, Burrows EA . Assessing the teratogenic potential of angiotensin-converting enzyme inhibitors in pregnancy Aust N Z J Obstet Gynaecol 1998 38: 306–11
Chisholm CA, Chescheir NC, Kennedy M . Reversible oligohydramnios in a pregnancy with angiotensin-converting enzyme inhibitor exposure Am J Perinatol 1997 14: 511–3
PDR.NET. Cardiovascular Agents: Angiotensin Converting Enzyme (ACE) Inhibitors Montvale, New Jersey: Medical Economics Company, Inc 2002 vol 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muller, P., James, A. Pregnancy With Prolonged Fetal Exposure to an Angiotensin-Converting Enzyme Inhibitor. J Perinatol 22, 582–584 (2002). https://doi.org/10.1038/sj.jp.7210766
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210766